Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Attorney General

NJ Attorney General Announces Suit Against Purdue Pharma Alleging Scheme to ‘Mainstream’ Addictive Opioids for Profit

NJ Attorney General Christopher Porrino

Trenton, NJ, November 1, 2017 — Attorney General Christopher S. Porrino announced yesterday that the State has filed a five-count lawsuit against Purdue Pharma L.P., alleging a “direct” link between New Jersey’s opioid crisis and a push by Purdue to boost profits by deceptively marketing addictive medications and exploiting vulnerable new markets, such as the elderly and the “opioid-naïve.”

The lawsuit charges Purdue with widespread deception about the risks and benefits of these dangerously addictive pain medications.

“When we point the finger of blame for the deadly epidemic that has killed thousands in New Jersey, Purdue is in the bullseye of the target,” said Attorney General Porrino on Tuesday. “[M]y office took the first step toward holding them legally and financially responsible for their deception.” Continue reading

HINJ, PhRMA, Others Challenge NJ Attorney General’s Push to Limit Compensation to Prescribing Doctors

Dean J. Paranicas, President and Chief Executive Officer, HINJ

Trenton, NJ, October 23, 2017 — WHYY Public Radio Philadelphia’s Joe Hernandez reports that, in a new push to fight the opioid crisis, New Jersey officials are trying to stop the flow of legal but highly addictive painkillers at the source: doctors.

A proposed rule change by N.J. Attorney General Christopher Porrino would restrict the amount of money and other compensation drug companies can give out to doctors and other prescribers.  In doing so, state officials hope medical professionals will feel less pressure to prescribe opioids created and sold by the same companies that ply them with gifts and food.

But at a Thursday public hearing in Newark, representatives of the state’s pharmaceutical and medical industries criticized the potential rule change, questioning why it would apply to all drugs and claiming it would damage patient care and drive providers out of state. Continue reading

New Jersey Consumer Affairs Director to Step Down for Private Sector Position

Steve Lee

Trenton, NJ, August 9, 2017 — Attorney General Christopher S. Porrino announced yesterday that Steve Lee, Director of the New Jersey Division of Consumer Affairs, is leaving his post to take a job in the private sector.

Lee, who has led the state’s consumer protection agency since April 2014, will be going to work for Comcast Corporation as a Deputy General Counsel.

Lee began talks with the global media and technology company several months ago. His resignation is effective September 5. Continue reading